Israel’s First Pure-Play Cannabis Enterprise

Isracann, Israel’s first pure-play cannabis firm, is focused on becoming a premier, low-cost cannabis producer. Isracann is fully funded to execute on 230,000 sq ft of hybrid greenhouse.

Located in the cannabis research capital of the world, Isracann has relationships with the research, scientific and medical community to identify opportunities and develop a pipeline of drugs and devices.

The company is targeting an undersupplied domestic market and international markets via exports under Israel’s new framework for medical cannabis exports for 2020.

Business Model: Four Pillars

Isracann believes in four verticals to leverage its expertise and scale its business

Cultivation

Construction of 230,000 sq ft of hybrid greenhouse for ultra low cost production of high quality medical cannabis expected to be completed by late Q4 2019. Being built from the ground-up specific to our jurisdiction Isracann will be a major cultivator in Israel.

Distribution

Israel has a massive domestic undersupply and over 10,000 patients on waitlist. Close proximity to the EU allows Isracann to efficiently export under new legislation passed January 2019. Through a partnership with a distribution company in Malta Isracann has access to the largest cannabis marketplace in the world.

Branding

A centre for innovation and excellence, Israel’s well-known identity in regards to superior product development and production expertise allows for branding differentiation that resonates across the globe.

R&D Genetics

Partnership with leading Israeli research institutions and Universities to leverage their expertise and bring novel products to market. Access to the best genetics Israel has to offer will set Isracann apart on the global stage.

The Team

President & CEO Darryl Jones Mr. Jones has over 15 years of capital market experience and an established financial network. Prior to joining Isracann in 2018, Mr. Jones was an Investment advisor with PI Financial…
Read More
Advisory Board Member Brett Allan Mr. Allan has over 10 years of investment and capital markets experience. Mr. Allan has assisted in raising $400MM in the cannabis sector as the VP of Corporate Development for…
Read More
Strategic Advisor Nitin Kaushal Mr. Kaushal is a managing director with PwC in the Corporate Finance Practice in Toronto 25 years experience in the healthcare industry Mr. Kaushal has participated in capital market transactions…
Read More
Chairman & Director Mark Zegal Mark Zegal is an Israeli businessman with specialization in the capital markets. Formerly a member of the Chicago Board of Options Exchange, Mr. Zegal has 20 years of experience in…
Read More
Advisory Board Member Mathew Christopherson Mr. Christopherson is the co-founder, president and chief executive officer of Higharchy Cannabis Group, a consortium of companies focused on consumer brands and retail experiences in the cannabis sector. Throughout…
Read More
COO Israel Moseson Mr. Moseson has been involved in the cannabis sector for over 5 years in Israel and is responsible for in-country operations. Prior to entering the cannabis industry, Mr. Moseson specialized…
Read More
Advisory Board Member Deepak Anand Mr. Anand former VP of Cannabis Compliance, a global leader in cannabis consulting and advisory. He is also the executive director of the Canadian National Medical Marijuana Association.
Read More
Stay up to date with IsraCann news & events